Literature DB >> 3321585

Prolonged survival of hamster-to-rat liver xenografts using splenectomy and cyclosporine administration.

L A Valdivia1, M Monden, M Gotoh, Y Hasuike, N Kubota, T Ichikawa, J Okamura, T Mori.   

Abstract

The immunosuppressive effect of splenectomy, alone or in combination with cyclosporine (CsA), was examined in hamster-to-rat orthotopic liver xenografts. The mean survival time was 7.3 +/- 0.5 days in untreated controls, 7.6 +/- 0.8 days with 40 mg/kg/day CsA, 7.2 +/- 0.4 days with splenectomy alone, and 17.6 +/- 5.6 days with splenectomy combined with 30 mg/kg/day CsA (P less than 0.01). The longest survival time was 27 days in this group. Marked enlargement of the spleen and high lymphocytotoxic antibody titer were characteristic of the unmodified recipients and those treated with CsA alone. Splenectomy by itself decreased the antibody formation without improvement of graft survival. In animals treated with the combined regimen, the lymphocytotoxic antibody titer was significantly suppressed, and the PMN and round cell infiltration were greatly reduced. Therefore, a synergistic effect was postulated between cyclosporine and splenectomy in this liver xenograft system.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3321585     DOI: 10.1097/00007890-198712000-00007

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  13 in total

1.  Differential survival of hamster-to-rat liver and cardiac xenografts under FK 506 immunosuppression.

Authors:  L A Valdivia; J J Fung; A J Demetris; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

2.  Humoral and cellular immunopathology of hepatic and cardiac hamster-into-rat xenograft rejection. Marked stimulation of IgM++bright/IgD+dull splenic B cells.

Authors:  A Langer; L A Valdivia; N Murase; J Woo; S Celli; J J Fung; T E Starzl; A J Demetris
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

3.  Hepatic transplantation at the University of Pittsburgh: new horizons and paradigms after 30 years of experience.

Authors:  K Abu-Elmagd; S Todo; J Fung; J Demetris; J Rakela; A S Rao; S Iwatsuki; T Starzl
Journal:  Clin Transpl       Date:  1994

4.  Long-term survival of heart and liver xenografts with splenectomy and FK 506.

Authors:  S Celli; L A Valdivia; J J Fung; A J Demetris; I R Marino; N Murase; T E Starzl
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

5.  Functional cooperation of xenoproteins after hamster-to-rat liver transplantation: With particular reference to hamster C3 and secretory component for rat IgA.

Authors:  S Celli; L A Valdivia; R H Kelly; A J Demetris; J J Fung; A S Rao; F Pan; M Tsugita; T E Starzl
Journal:  Xenotransplantation       Date:  1995-02-01       Impact factor: 3.907

6.  The effects of preoperative immunosuppressive therapy on ischemia and reperfusion (I/R) injury in healthy rats.

Authors:  Selcuk Kilinc; Sedat Tan; Efsun Hatice Kolatan; Dane Ruscuklu; Esra Satici; Mehmet Kemiksiz; Lutfi Dalkilic; Umut Eren Erdogdu; Cezmi Karaca
Journal:  Int Urol Nephrol       Date:  2013-09-08       Impact factor: 2.370

Review 7.  The biological basis of and strategies for clinical xenotransplantation.

Authors:  T E Starzl; L A Valdivia; N Murase; A J Demetris; P Fontes; A S Rao; R Manez; I R Marino; S Todo; A W Thomson
Journal:  Immunol Rev       Date:  1994-10       Impact factor: 12.988

8.  Hamster coagulation and serum proteins in rat recipients of hamster xenografts.

Authors:  L A Valdivia; J H Lewis; S Celli; F A Bontempo; J J Fung; A J Demetris; T E Starzl
Journal:  Transplantation       Date:  1993-08       Impact factor: 4.939

9.  Correction of congenital hyperbilirubinemia in homozygous Gunn rats by xenotransplantation of hamster livers.

Authors:  Yoshitaka Wakizaka; Toshio Miki; Abdul S Rao; Xue Wang; April L Goller; Anthony J Demetris; John J Fung; Thomas E Starzl; Luis A Valdivia
Journal:  Xenotransplantation       Date:  1997-11-01       Impact factor: 3.907

10.  Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs.

Authors:  N Murase; T E Starzl; A J Demetris; L Valdivia; M Tanabe; D Cramer; L Makowka
Journal:  Transplantation       Date:  1993-04       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.